AMGNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
AMGEN INC
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 5, 2026
$424.94−7.55 (-1.75%)
Close on Oct 19, 2026
- Market cap
- $231.17B
- P/E (TTM)
- 26.4
- Dividend yield
- 2.27%
Ownership
Institutional holdings as of Jun 30, 2026, from 13F filings
Held by institutions
82.7%
447M of 541M shares
Institutional holders
3,146
177 new, 122 sold out
Net institutional buying
9M
In Q2 2026
Insider trades, 12 months
0 buys · 14 sales
Net sold $29.33M
Shares held by institutions
Holders of more than 5%
Latest Schedule 13D (active) or 13G (passive) filed by each holder
| Holder | Shares | % of class | Filing | As of |
|---|---|---|---|---|
| BlackRock, Inc. | 40,830,830 | 7.60% | 13G (passive) amendment | Mar 31, 2025 |
| Vanguard Capital Management | 40,510,484 | 7.51% | 13G (passive) | Mar 31, 2026 |
| Capital World Investors | 29,596,119 | 5.50% | 13G (passive) | Mar 31, 2026 |
| Onyx Pharmaceuticals, Inc. | – | 9.00% | 13G (passive) amendment | Aug 22, 2024 |
| State Street Corporation | – | 5.52% | 13G (passive) amendment | Dec 31, 2023 |
Top institutional holders
13F holdings as of Jun 30, 2026
| Holder | Shares | % of AMGN | Value | Change | % of portfolio |
|---|---|---|---|---|---|
| BlackRock, Inc. | 49,362,016 | 9.13% | $17.87B | +2,261,544 | 0.27% |
| Vanguard Capital Management LLC | 35,250,101 | 6.52% | $12.76B | +235,869 | 0.27% |
| State Street Corp | 30,560,537 | 5.65% | $11.07B | +12,049 | 0.33% |
| Capital World Investors | 29,075,329 | 5.38% | $10.53B | −213,014 | 1.24% |
| Invesco Ltd. | 16,320,446 | 3.02% | $5.91B | +434,940 | 0.47% |
| Geode Capital Management, LLC | 15,696,068 | 2.90% | $5.67B | +265,544 | 0.30% |
| Charles Schwab Investment Management Inc | 15,034,038 | 2.78% | $5.44B | +2,260,652 | 0.72% |
| Vanguard Portfolio Management LLC | 14,853,366 | 2.75% | $5.38B | +232,218 | 0.24% |
| Morgan Stanley | 13,653,692 | 2.53% | $4.94B | −2,182,366 | 0.26% |
| Wells Fargo & Company/Mn | 7,235,462 | 1.34% | $2.62B | +147,452 | 0.42% |
| Primecap Management Co/Ca/ | 6,756,962 | 1.25% | $2.45B | −2,117,167 | 1.45% |
| Capital Research Global Investors | 6,272,625 | 1.16% | $2.27B | −682,720 | 0.32% |
| Northern Trust Corp | 6,200,994 | 1.15% | $2.25B | −16,844 | 0.26% |
| Norges Bank | 5,625,584 | 1.04% | $2.04B | New | 0.20% |
| UBS Asset Management Americas Inc | 5,390,910 | 1.00% | $1.95B | +605,928 | 0.35% |
| Bank Of America Corp /De/ | 5,058,830 | 0.94% | $1.83B | −62,198 | 0.12% |
| Royal Bank of Canada | 4,328,785 | 0.80% | $1.57B | −142,660 | 0.23% |
| Goldman Sachs Group Inc | 4,130,732 | 0.76% | $1.50B | −89,257 | 0.13% |
| Price T Rowe Associates Inc /Md/ | 3,956,992 | 0.73% | $1.43M | +2,089,803 | 0.14% |
| Amundi | 3,890,189 | 0.72% | $1.41B | +512,883 | 0.34% |
Institutional buying and selling by quarter
Positions opened, added to, reduced and closed by 13F filers
| Quarter | Holders | Shares held | % of shares | New / added | Reduced / closed | Shares bought | Shares sold |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 3,146 | 447M | 82.7% | 177 / 1271 | 1226 / 122 | 33M | 23M |
| Q1 2026 | 3,145 | 440M | 81.3% | 225 / 1213 | 1250 / 126 | 84M | 39M |
| Q4 2025 | 3,091 | 451M | 83.4% | 418 / 1184 | 1112 / 95 | 45M | 20M |
| Q3 2025 | 2,826 | 427M | 79.1% | 145 / 1131 | 1152 / 133 | 18M | 27M |
| Q2 2025 | 2,857 | 437M | 80.9% | 146 / 1236 | 1094 / 182 | 26M | 17M |
| Q1 2025 | 2,932 | 429M | 79.3% | 250 / 1135 | 1187 / 132 | 35M | 22M |
| Q4 2024 | 2,860 | 419M | 77.5% | 317 / 1079 | 1131 / 236 | 38M | 33M |
| Q3 2024 | 2,829 | 417M | 77.1% | 174 / 1098 | 1140 / 98 | 63M | 15M |
| Q2 2024 | 2,789 | 415M | 76.8% | 208 / 1146 | 1068 / 100 | 22M | 50M |
| Q1 2024 | 2,719 | 445M | 82.3% | 189 / 1128 | 1021 / 149 | 40M | 25M |
| Q4 2023 | 2,717 | 430M | 79.6% | 343 / 981 | 1045 / 89 | 41M | 16M |
| Q3 2023 | 2,504 | 407M | 75.2% | 253 / 981 | 912 / 111 | 20M | 18M |
Top mutual fund and ETF holders
Latest monthly portfolio reports (Form N-PORT)
| Fund | Shares | % of AMGN | Value | % of fund | As of |
|---|---|---|---|---|---|
| Vanguard Total Stock Market Index Fund | 17,134,234 | 3.17% | $6.20B | 0.27% | Jun 30, 2026 |
| Vanguard 500 Index Fund | 13,987,160 | 2.59% | $5.07B | 0.30% | Jun 30, 2026 |
| Invesco QQQ Trust, Series 1 | 11,456,486 | 2.12% | $4.15B | 0.85% | Jun 30, 2026 |
| Schwab U.S. Dividend Equity ETF | 9,787,012 | 1.81% | $3.30B | 3.47% | May 31, 2026 |
| Income Fund of America | 7,758,812 | 1.44% | $2.99B | 2.02% | Jul 31, 2026 |
| iShares Core S&P 500 ETF | 7,422,554 | 1.37% | $2.69B | 0.30% | Jun 30, 2026 |
| American Balanced Fund | 7,087,896 | 1.31% | $2.57B | 0.89% | Jun 30, 2026 |
| Fidelity 500 Index Fund | 6,890,954 | 1.27% | $2.32B | 0.28% | May 31, 2026 |
| Washington Mutual Investors Fund | 6,056,889 | 1.12% | $2.33B | 1.07% | Jul 31, 2026 |
| Vanguard Value Index Fund | 5,136,838 | 0.95% | $1.86B | 0.73% | Jun 30, 2026 |
| Vanguard Primecap Fund | 4,349,446 | 0.80% | $1.58B | 1.64% | Jun 30, 2026 |
| State Street(R) Health Care Select Sector SPDR(R) ETF | 3,812,905 | 0.71% | $1.38B | 3.40% | Jun 30, 2026 |
| Growth Fund of America | 3,336,048 | 0.62% | $1.12B | 0.31% | May 31, 2026 |
| Vanguard Dividend Appreciation Index Fund | 3,053,644 | 0.56% | $1.18B | 0.90% | Jul 31, 2026 |
| Vanguard Institutional Index Fund | 2,929,913 | 0.54% | $1.06B | 0.30% | Jun 30, 2026 |
Officers, directors and major owners
People who filed Forms 3, 4 or 5 in the last two years
| Name | Role | Shares owned | % of shares | Latest filing |
|---|---|---|---|---|
| Robert A. Bradway | Chairman, CEO and President, Director | 655,220 | 0.12% | May 11, 2026 |
| Thomas J.W. Dittrich | EVP & CFO | 16,860 | 0.00% | Sep 4, 2026 |
| Rachna Khosla | SVP, Business Development | 7,656 | 0.00% | Aug 13, 2026 |
| Matthew C. Busch | VP, Finance & CAO | 5,080 | 0.00% | Aug 12, 2026 |
| Derek Miller | SVP, Human Resources | 12,462 | 0.00% | Aug 7, 2026 |
| Nancy A. Grygiel | SVP & CCO | 8,447 | 0.00% | Aug 7, 2026 |
| Murdo Gordon | EVP, Global Commercial Ops | 51,222 | 0.01% | May 11, 2026 |
| Esteban Santos | EVP, Operations | 83,757 | 0.02% | May 11, 2026 |
| David M. Reese | EVP & Chief Technology Officer | 42,256 | 0.01% | May 11, 2026 |
| Peter H. Griffith | EVP & CFO | 50,150 | 0.01% | May 11, 2026 |
| James E. Bradner | EVP, Research and Development | 30,016 | 0.01% | May 11, 2026 |
| Jonathan P. Graham | EVP & Gen. Counsel & Sec. | 39,712 | 0.01% | May 11, 2026 |
| Michael V. Drake | Director | 5,876 | 0.00% | Aug 10, 2026 |
| Charles M. Holley | Director | 14,250 | 0.00% | Aug 10, 2026 |
| Omar Ishrak | Director | 7,486 | 0.00% | Aug 10, 2026 |
| Mary E. Klotman | Director | 2,211 | 0.00% | May 21, 2026 |
| Robert Eckert | Director | 26,251 | 0.00% | May 21, 2026 |
| Amy E. Miles | Director | 5,640 | 0.00% | May 21, 2026 |
| Tyler Jacks | Director | 18,284 | 0.00% | May 21, 2026 |
| Greg C. Garland | Director | 13,848 | 0.00% | May 21, 2026 |
| Wanda M. Austin | Director | 8,018 | 0.00% | May 21, 2026 |
| Brian Druker | Director | 8,391 | 0.00% | May 21, 2026 |
| Ellen Jamison Kullman | Director | 14,536 | 0.00% | May 21, 2026 |
Insider trades
Common stock transactions reported on Form 4, newest first
| Insider | Date | Transaction | Shares | Price | Value | Shares after |
|---|---|---|---|---|---|---|
| Rachna Khosla SVP, Business Development | Aug 13, 2026 | Option exercise | +1,252 | $162.60 | $203.58K | 7,656 |
| Rachna Khosla SVP, Business Development | Aug 13, 2026 | Sale | −1,252 | $416.43 | $521.37K | 6,404 |
| Rachna Khosla SVP, Business Development | Aug 11, 2026 | Sale | −2,000 | $412.57 | $825.14K | 6,404 |
| Matthew C. Busch VP, Finance & CAO | Aug 7, 2026 | Award | +730 | – | – | 5,080 |
| Omar Ishrak Director | Aug 7, 2026 | Award | +85.17 | – | – | 7,486 |
| Michael V. Drake Director | Aug 7, 2026 | Award | +63.88 | – | – | 5,876 |
| Charles M. Holley Director | Aug 7, 2026 | Award | +103.42 | – | – | 12,990 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Sale | −1,821 | $402.54 | $733.03K | 12,462 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Option exercise | +1,821 | $177.46 | $323.15K | 14,283 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Option exercise | +2,069 | $162.60 | $336.42K | 14,531 |
| Derek Miller SVP, Human Resources | Aug 6, 2026 | Sale | −2,069 | $402.54 | $832.86K | 12,462 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Option exercise | +1,000 | $177.31 | $177.31K | 8,340 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Option exercise | +1,970 | $177.46 | $349.60K | 9,310 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Sale | −1,970 | $402.16 | $792.26K | 7,340 |
| Nancy A. Grygiel SVP & CCO | Aug 6, 2026 | Sale | −1,000 | $402.16 | $402.16K | 7,340 |
| Wanda M. Austin Director | May 19, 2026 | Award | +665 | – | – | 8,018 |
| Brian Druker Director | May 19, 2026 | Award | +665 | – | – | 8,391 |
| Tyler Jacks Director | May 19, 2026 | Award | +665 | – | – | 18,284 |
| Michael V. Drake Director | May 19, 2026 | Award | +665 | – | – | 5,774 |
| Amy E. Miles Director | May 19, 2026 | Award | +665 | – | – | 5,640 |
| Greg C. Garland Director | May 19, 2026 | Award | +665 | – | – | 13,848 |
| Omar Ishrak Director | May 19, 2026 | Award | +665 | – | – | 7,359 |
| Mary E. Klotman Director | May 19, 2026 | Award | +665 | – | – | 2,211 |
| Robert Eckert Director | May 19, 2026 | Award | +665 | – | – | 26,251 |
| Charles M. Holley Director | May 19, 2026 | Award | +665 | – | – | 12,799 |
| Ellen Jamison Kullman Director | May 19, 2026 | Award | +665 | – | – | 14,536 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 7, 2026 | Tax withholding | −499 | $331.11 | $165.22K | 39,712 |
| Murdo Gordon EVP, Global Commercial Ops | May 7, 2026 | Tax withholding | −615 | $331.11 | $203.63K | 51,222 |
| Peter H. Griffith EVP & CFO | May 7, 2026 | Tax withholding | −556 | $331.11 | $184.10K | 50,150 |
| David M. Reese EVP & Chief Technology Officer | May 7, 2026 | Tax withholding | −556 | $331.11 | $184.10K | 42,256 |
| Derek Miller SVP, Human Resources | May 7, 2026 | Tax withholding | −151 | $331.11 | $50.00K | 12,444 |
| Robert A. Bradway Chairman, CEO and President, Director | May 7, 2026 | Tax withholding | −2,079 | $331.11 | $688.38K | 505,160 |
| Rachna Khosla SVP, Business Development | May 7, 2026 | Tax withholding | −93 | $331.11 | $30.79K | 8,394 |
| Matthew C. Busch VP, Finance & CAO | May 7, 2026 | Tax withholding | −41 | $331.11 | $13.58K | 4,344 |
| Nancy A. Grygiel SVP & CCO | May 7, 2026 | Tax withholding | −88 | $331.11 | $29.14K | 7,330 |
| James E. Bradner EVP, Research and Development | May 7, 2026 | Tax withholding | −446 | $331.11 | $147.68K | 30,016 |
| Esteban Santos EVP, Operations | May 7, 2026 | Tax withholding | −522 | $331.11 | $172.84K | 82,847 |
| Matthew C. Busch VP, Finance & CAO | May 6, 2026 | Tax withholding | −50 | $329.59 | $16.48K | 4,385 |
| Rachna Khosla SVP, Business Development | May 6, 2026 | Tax withholding | −79 | $329.59 | $26.04K | 8,487 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 6, 2026 | Tax withholding | −408 | $329.59 | $134.47K | 40,211 |
| Esteban Santos EVP, Operations | May 6, 2026 | Tax withholding | −427 | $329.59 | $140.73K | 83,369 |
| Murdo Gordon EVP, Global Commercial Ops | May 6, 2026 | Tax withholding | −502 | $329.59 | $165.45K | 51,837 |
| James E. Bradner EVP, Research and Development | May 6, 2026 | Tax withholding | −407 | $329.59 | $134.14K | 30,462 |
| David M. Reese EVP & Chief Technology Officer | May 6, 2026 | Tax withholding | −454 | $329.59 | $149.63K | 42,812 |
| Robert A. Bradway Chairman, CEO and President, Director | May 6, 2026 | Tax withholding | −1,702 | $329.59 | $560.96K | 507,239 |
| Nancy A. Grygiel SVP & CCO | May 6, 2026 | Tax withholding | −76 | $329.59 | $25.05K | 7,418 |
| Derek Miller SVP, Human Resources | May 6, 2026 | Tax withholding | −123 | $329.59 | $40.54K | 12,595 |
| Peter H. Griffith EVP & CFO | May 6, 2026 | Tax withholding | −502 | $329.59 | $165.45K | 50,706 |
| Michael V. Drake Director | May 5, 2026 | Award | +79.64 | – | – | 5,109 |
| Matthew C. Busch VP, Finance & CAO | May 5, 2026 | Award | +455 | – | – | 4,435 |
| Charles M. Holley Director | May 5, 2026 | Award | +128.95 | – | – | 12,134 |
| Rachna Khosla SVP, Business Development | May 5, 2026 | Award | +500 | – | – | 8,566 |
| Jonathan P. Graham EVP & Gen. Counsel & Sec. | May 5, 2026 | Award | +2,609 | – | – | 40,619 |
| Esteban Santos EVP, Operations | May 5, 2026 | Award | +2,730 | – | – | 83,796 |
| Murdo Gordon EVP, Global Commercial Ops | May 5, 2026 | Award | +3,640 | – | – | 52,339 |
| James E. Bradner EVP, Research and Development | May 5, 2026 | Award | +3,337 | – | – | 30,869 |
| Omar Ishrak Director | May 5, 2026 | Award | +106.19 | – | – | 6,694 |
| David M. Reese EVP & Chief Technology Officer | May 5, 2026 | Award | +2,912 | – | – | 43,266 |
| Robert A. Bradway Chairman, CEO and President, Director | May 5, 2026 | Award | +12,136 | – | – | 508,941 |
| Nancy A. Grygiel SVP & CCO | May 5, 2026 | Award | +485 | – | – | 7,494 |
Awards, option exercises, tax withholding and gifts are shown alongside open-market buys and sales. Each name links to the filing on SEC EDGAR.
Planned insider sales
Notices of proposed sale filed on Form 144 before shares are sold
| Seller | Filed | Shares | Market value | Planned sale | Acquired through |
|---|---|---|---|---|---|
| Rachna Khosla Officer | Aug 13, 2026 | 1,252 | $516.78K | Aug 13, 2026 | Stock Option Exercise |
| Rachna Khosla Officer | Aug 11, 2026 | 2,000 | $828.42K | Aug 11, 2026 | Stock award |
| Nancy A. Grygiel Officer | Aug 6, 2026 | 2,670 | $1.19M | Aug 6, 2026 | Cashless Stock Option Exercise |
| Nancy A. Grygiel Officer | Aug 6, 2026 | 2,970 | $1.19M | Aug 6, 2026 | Cashless Stock Option Exercise |
| Miller Derek Officer | Aug 6, 2026 | 3,890 | $1.57M | Aug 6, 2026 | Acquired as compensation -- Stock Options |
| Nancy A. Grygiel Officer | May 4, 2026 | 1,237 | $400.45K | May 4, 2026 | Performance Unit |
| Esteban Santos Associate | Feb 27, 2026 | 54,792 | $20.77M | Feb 26, 2026 | Equity Compensation 2016 Stock Option Grant |
| Matthew C. Busch ASSOCIATED TO AFFILIATE | Feb 19, 2026 | 1,000 | $375.00K | Feb 19, 2026 | Stock Award |
| Nancy A. Grygiel Officer | Nov 20, 2025 | 3,139 | $1.06M | Nov 20, 2025 | Cashless Stock Option Exercise |
| Murdo Gordon Officer | Nov 12, 2025 | 6,879 | $2.32M | Nov 12, 2025 | Restricted Stock Award |
| Rachna Khosla Officer | Nov 12, 2025 | 890 | $300.30K | Nov 12, 2025 | Stock Award |
| Nancy A. Grygiel Officer | Aug 20, 2025 | 1,267 | $372.91K | Aug 20, 2025 | RSE/DEU Grants |
| Rachna Khosla Officer | Jun 5, 2025 | 1,500 | $435.00K | Jun 5, 2025 | Stock Award |
| Matthew C. Busch Officer | May 2, 2025 | 1,000 | $281.44K | May 2, 2025 | Compensation |
| M. Reese & Joan I. Chuco-Ttee Chu-Reese Family Trustu/A Dtd 01/07/2005 David Officer | Feb 21, 2025 | 25,225 | $7.68M | Feb 21, 2025 | Restricted stock vesting under a registered plan |